Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis.
Is the treatment of multiple sclerosis headed in the wrong direction?
Neuromyelitis Optica With Onset in Childhood and Adolescence.
Clinically meaningful performance benchmarks in MS: Timed 25-Foot Walk and the real world.
[Chronic cerebrospinal venous insufficiency--pathophysiology and treament].
DYNACIN (MINOCYCLINE)
Effects of Topiramate on Dysaesthetic Pain in a Patient with Multiple Sclerosis.
Association between pathological and MRI findings in multiple sclerosis.
Targeting human oligodendrocyte progenitors for myelin repair.
Abrogation of β-Catenin Signaling in Oligodendrocyte Precursor Cells Reduces Glial Scarring and Promotes Axon Regeneration after CNS Injury.
Decreased signal transducers and activators of transcription (STAT) protein expression in lymphatic organs during EAE development in mice.
Tumefactive MS lesions under fingolimod: A case report and literature review.
The path to self-management: a qualitative study involving older people with multiple sclerosis.
Effect of Fampridine-PR (prolonged released 4-aminopyridine) on the manual functions of patients with Multiple Sclerosis.
Topographical and Biological Evidence Revealed FTY720-Mediated Anergy-Polarization of Mouse Bone Marrow-Derived Dendritic Cells In Vitro.
Differential diagnosis for cervical spondylotic myelopathy: literature review.
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide.
The roles of cathelicidin LL-37 in immune defences and novel clinical applications.
The risk of fracture in incident multiple sclerosis patients: The Danish National Health Registers.
FTY720 Impairs Mucosal Immunity and Clearance of the Enteric Pathogen Citrobacter rodentium.
[Research progress of the selective sphingosine-1-phosphate receptor 1 agonists].
Post-Partum Treatment With Immunoglobulin Does Not Prevent Relapses of Multiple Sclerosis in the Mother.
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
A signal-to-noise-ratio-based analysis of multifocal visual-evoked potentials in multiple sclerosis risk assessment.
Stelara (Ustekinumab) receives FDA Approval for Treatment of Moderate to Severe Plaque Psoriasis with Four-Times-A-Year Maintenance Dosing

Pages